Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02204228 · ClinicalTrials.gov registry record
TITAN™ Reverse Shoulder System
A clinical trial, sponsored by Smith & Nephew.
- Terminated
- Registry status
- 151
- Enrollment target
NCT02204228 is a clinical trial that was terminated before completion, run by Smith & Nephew. The registered enrollment target is 151 participants.
The verdict
NCT02204228 was terminated before completion, sponsored by Smith & Nephew.
- TERMINATED
- Registry status
- 151 participants
- Enrollment target
Study Summary
The Integra® TITAN™ Reverse Shoulder System (TRS) is a semi-constrained total shoulder construct. When used under the conditions and purposes intended the TRS will relieve pain and restore some functional joint motion to the affected shoulder. The purpose of this study is to assess the short, mid and long term outcomes of the TITAN™ Reverse Shoulder System.
Interventions
- DEVICE TITAN™ Reverse Shoulder System (TRS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2014-09 |
| Est. Completion | 2023-12-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02204228
The ClinicalTrials.gov registry entry for NCT02204228 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Smith & Nephew, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TITAN™ Reverse Shoulder System (TRS) is the first listed.
NCT02204228 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02204228 about?
NCT02204228 is a clinical study titled "TITAN™ Reverse Shoulder System". The Integra® TITAN™ Reverse Shoulder System (TRS) is a semi-constrained total shoulder construct. When used under the conditions and purposes intended the TRS will relieve pain and restore some functional joint motion to the affected shoulder. The purpose of this study is to assess the short, mid an...
What is the current status of trial NCT02204228?
This trial is currently terminated. The enrollment target is 151 participants. The study started on 2014-09. Estimated completion is 2023-12-14.
What interventions are being tested in trial NCT02204228?
The interventions under investigation include: TITAN™ Reverse Shoulder System (TRS) (DEVICE).
Who is sponsoring clinical trial NCT02204228?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.